S
Sharhzad Motaghi
Researcher at McMaster University
Publications - 3
Citations - 709
Sharhzad Motaghi is an academic researcher from McMaster University. The author has contributed to research in topics: Absolute risk reduction & Antiviral antibody. The author has an hindex of 2, co-authored 3 publications receiving 342 citations.
Papers
More filters
Journal ArticleDOI
Drug treatments for covid-19: living systematic review and network meta-analysis.
Reed A C Siemieniuk,Jessica J Bartoszko,Long Ge,Dena Zeraatkar,Ariel Izcovich,Elena Kum,Hector Pardo-Hernandez,Anila Qasim,Juan Pablo Diaz Martinez,Bram Rochwerg,Francois Lamontagne,Mi Ah Han,Qin Liu,Arnav Agarwal,Arnav Agarwal,Thomas Agoritsas,Derek K. Chu,Rachel Couban,Ellen Cusano,Andrea Darzi,Tahira Devji,Bo Fang,Carmen Fang,Signe Flottorp,Signe Flottorp,Farid Foroutan,Farid Foroutan,Maryam Ghadimi,Diane Heels-Ansdell,Kimia Honarmand,Liangying Hou,Xiaorong Hou,Quazi Ibrahim,Assem M. Khamis,Bonnie Lam,Mark Loeb,Maura Marcucci,Shelley McLeod,Sharhzad Motaghi,Srinivas Murthy,Reem A. Mustafa,Reem A. Mustafa,John Neary,Gabriel Rada,Irbaz Bin Riaz,Behnam Sadeghirad,Nigar Sekercioglu,Lulu Sheng,Ashwini Sreekanta,Charlotte Switzer,Britta Tendal,Lehana Thabane,George Tomlinson,Tari Turner,Per Olav Vandvik,Robin W.M. Vernooij,Andrés Viteri-García,Ying Wang,Liang Yao,Zhikang Ye,Gordon H Guyatt,Romina Brignardello-Petersen +61 more
TL;DR: Glucocorticoids probably reduce mortality and mechanical ventilation in patients with covid-19 compared with standard care and the effectiveness of most interventions is uncertain because most of the randomised controlled trials so far have been small and have important study limitations.
Journal ArticleDOI
Prophylaxis against covid-19: living systematic review and network meta-analysis.
Jessica J Bartoszko,Reed A C Siemieniuk,Elena Kum,Anila Qasim,Dena Zeraatkar,Long Ge,Mi Ah Han,Behnam Sadeghirad,Arnav Agarwal,Arnav Agarwal,Thomas Agoritsas,Derek K. Chu,Rachel Couban,Andrea Darzi,Tahira Devji,Maryam Ghadimi,Kimia Honarmand,Ariel Izcovich,Assem M. Khamis,Francois Lamontagne,Mark Loeb,Maura Marcucci,Shelley McLeod,Sharhzad Motaghi,Srinivas Murthy,Reem A. Mustafa,John Neary,Hector Pardo-Hernandez,Gabriel Rada,Bram Rochwerg,Charlotte Switzer,Britta Tendal,Lehana Thabane,Per Olav Vandvik,Robin W.M. Vernooij,Andrés Viteri-García,Ying Wang,Liang Yao,Zhikang Ye,Gordon H Guyatt,Romina Brignardello-Petersen +40 more
TL;DR: In this paper, the authors compared the effects of drug prophylaxis on SARS-CoV-2 infection and covid-19 using living systematic review and network meta-analysis.
Journal ArticleDOI
Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis.
Reed A C Siemieniuk,Jessica J Bartoszko,Juan Pablo Diaz Martinez,Elena Kum,Anila Qasim,Dena Zeraatkar,Ariel Izcovich,Sophia O Mangala,Long Ge,Mi Ah Han,Thomas Agoritsas,Donald M. Arnold,Camila Ávila,Derek K. Chu,Rachel Couban,Ellen Cusano,Andrea Darzi,Tahira Devji,Farid Foroutan,Maryam Ghadimi,Assem M. Khamis,Francois Lamontagne,Mark Loeb,Anna Miroshnychenko,Sharhzad Motaghi,Srinivas Murthy,Reem A. Mustafa,Reem A. Mustafa,Gabriel Rada,Bram Rochwerg,Charlotte Switzer,Per Olav Vandvik,Robin W.M. Vernooij,Ying Wang,Liang Yao,Gordon H. Guyatt,Romina Brignardello-Petersen +36 more
TL;DR: In this paper, the authors evaluated the efficacy and safety of antiviral antibody therapies and blood products for the treatment of novel coronavirus disease 2019 (covid-19), with pairwise meta-analysis for outcomes with insufficient data.